drugset / Trial / NCT03013881
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of the study is to evaluate the safety, tolerability, and pharmacokinetics of escalating single-dose of UB-921 in healthy male volunteers.
Timeline
- Start
- 2018-03-05
- Primary completion
- 2018-10-08
- Completion
- 2019-04-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Trastuzumab | Monoclonal antibody | 6 mg/kg | Intravenous |
| Subject | UB-921 | Unknown | 2 mg/kg | Intravenous |
| Subject | UB-921 | Unknown | 6 mg/kg | Intravenous |
| Subject | UB-921 | Unknown | 8 mg/kg | Intravenous |